Although the precise roles of S100A8/A9 in cancer remain a subject of debate, an increasing body of research suggests that S100A8/A9 may promote cancer progression by activating oncogenic signaling pathways and influencing the tumor immune microenvironment. This evidence concerns the gene S100A8 and neoplasm.